Saito 2010.
Trial name or title | JCOG0505 |
Methods | Phase III RCT |
Participants | Women with IVB persistent or recurrent cervical cancer not amenable to curative treatment with local therapy |
Interventions | Arm 1: paclitaxel 135 mg/m2 over 24 h d1 plus carboplatin AUC 5 d1 q21 Arm 2: paclitaxel 135 mg/m2 over 24 h d1 plus cisplatin 50 mg/m2 2 h d2 q21 |
Outcomes | OS PFS Toxicity Unplanned hospital admissions (surrogate for QoL) |
Starting date | 21 February 2006 |
Contact information | kitagawa.ryo@east.ntt.co.jp |
Notes | Planned sample size 250 |
AUC: area under curve; d: day; h: hour; OS: overall survival; PFS: progression‐free survival; QoL: quality of life; RCT: randomised controlled trial.